Ascentage Pharma
AAPG
11.97
-0.47
-3.78%
Ascentage Pharma
US · AAPG
#3045 by market cap
Listed 2025
11.97
-0.47
-3.78%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Ascentage Pharma
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
- Founded
- 2009
- CEO
- Dr. Dajun Yang, M.D.,PhD
- Employees
- 767
- Headquarters
- Suzhou, Jiangsu, China
- Fiscal year end
- 12-31
- Website
- ascentage.com
Company profile
- Exchange
- US
- Symbol
- AAPG
- Market-cap rank
- #3045
- Listing date
- 2025-01-24
- Market cap
- 1.12B
- Float cap
- 868.55M
- Shares out
- 93.39M
- Float shares
- 72.56M
Sectors & themes
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Ascentage Pharma discussion 0 comments